Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis

Hepatology

Volumn 63, Issue 4, 2016, Pages 1325-1339

  Fujita, Tomoko ^a   Soontrapa, Kitipong ^a,b   Ito, Yoshiya ^c   Iwaisako, Keiko ^a,d   Moniaga, Catharina Sagita ^a   Asagiri, Masataka ^a   Majima, Masataka ^c   Narumiya, Shuh ^a,e  

^a KYOTO UNIVERSITY   (Japan)

^b MAHIDOL UNIVERSITY   (Thailand)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; CD3 ANTIGEN; CD4 ANTIGEN; CHEMOKINE; CONCANAVALIN A; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LIVER PROTECTIVE AGENT; MESSENGER RNA; PROSTAGLANDIN D2; PROTEIN C JUN; TUMOR NECROSIS FACTOR ALPHA;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL MIGRATION; DOWN REGULATION; DRUG ACTIVATION; ENZYME PHOSPHORYLATION; HEPATIC MICROCIRCULATION; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE MEDIATED HEPATITIS; LEUKOCYTE ADHERENCE; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; LIVER PROTECTION; LIVER SINUSOID; MICROCIRCULATION; MOUSE; MOUSE MODEL; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; STELLATE CELL; ANIMAL; C57BL MOUSE; CASE CONTROL STUDY; DISEASE MODEL; DRUG EFFECTS; FEMALE; HEPATITIS C; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KUPFFER CELL; MALE; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TOXIC HEPATITIS;

ANIMALS; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CHEMOKINES; CONCANAVALIN A; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; HEPATIC STELLATE CELLS; HEPATITIS C; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; KUPFFER CELLS; MALE; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945952555     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28112     Document Type: Article

References (43)

1. Jenne CN, Kubes P. Immune surveillance by the liver. Nat Immunol 2013;14:996-1006.
2. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009;89:1269-1339.
3. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008;48:322-335.
4. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.
5. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013;499:97-101.
6. Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90:196-203.
7. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-198.
8. Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996;23:1608-1615.
9. 2 as the major eicosanoid from liver endothelial and Kupffer cells. Biochim Biophys Acta 1988;959:143-152.
10. Hirata T, Narumiya S. Prostanoid receptors. Chem Rev 2011;111:6209-6230.
11. 2 as a mediator of allergic asthma. Science 2000;287:2013-2017.
12. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. "Green mice" as a source of ubiquitous green cells. FEBS Lett 1997;407:313-319.
13. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
14. Schumann J, Wolf D, Pahl A, Brune K, Papadopoulos T, van Rooijen N, et al. Importance of Kupffer cells for T-cell-dependent liver injury in mice. Am J Pathol 2000;157:1671-1683.
15. 2 receptor CRTH2: structure, properties, and functions in leukocytes. Prostaglandins Leukot Essent Fatty Acids 2003;69:169-177.
16. Oo YH, Shetty S, Adams DH. The role of chemokines in the recruitment of lymphocytes to the liver. Dig Dis 2010;28:31-44.
17. Chen F, Zhu HH, Zhou LF, Li J, Zhao LY, Wu SS, et al. Genes related to the very early stage of ConA-induced fulminant hepatitis: a gene-chip-based study in a mouse model. BMC Genomics 2010;11:240.
18. Hayden MS, Ghosh S. Regulation of NF-kappaB by TNF family cytokines. Semin Immunol 2014;26:253-266.
19. Sun SC, Ganchi PA, Ballard DW, Greene WC. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993;259:1912-1915.
20. Sabio G, Davis RJ. TNF and MAP kinase signalling pathways. Semin Immunol 2014;26:237-245.
21. Kato J, Okamoto T, Motoyama H, Uchiyama R, Kirchhofer D, Van Rooijen N, et al. Interferon-gamma-mediated tissue factor expression contributes to T-cell-mediated hepatitis through induction of hypercoagulation in mice. Hepatology 2013;57:362-372.
22. Kanaoka Y, Urade Y. Hematopoietic prostaglandin D synthase. Prostaglandins Leukot Essent Fatty Acids 2003;69:163-167.
23. Sakurai H, Suzuki S, Kawasaki N, Nakano H, Okazaki T, Chino A, et al. Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem 2003;278:36916-36923.
24. Sass G, Koerber K, Bang R, Guehring H, Tiegs G. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 2001;107:439-447.
25. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008;451:914-918.
26. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992;267:16323-16329.
27. Jagodic M, Becanovic K, Sheng JR, Wu X, Backdahl L, Lorentzen JC, et al. An advanced intercross line resolves Eae18 into two narrow quantitative trait loci syntenic to multiple sclerosis candidate loci. J Immunol 2004;173:1366-1373.
28. Miyazawa Y, Tsutsui H, Mizuhara H, Fujiwara H, Kaneda K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology 1998;27:497-506.
29. 2 receptor DP agonist on liver myofibroblast contraction. J Pharmacol Sci 2011;116:197-203.
30. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med 1996;184:1397-1411.
31. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, et al. Immune mechanisms of concanavalin A model of autoimmune hepatitis. World J Gastroenterol 2012;18:119-125.
32. Zimmermann HW, Trautwein C, Tacke F. Functional role of monocytes and macrophages for the inflammatory response in acute liver injury. Front Physiol 2012;3:56.
33. Kamthong PJ, Wu M. Inhibitor of nuclear factor-kappaB induction by cAMP antagonizes interleukin-1-induced human macrophage-colony-stimulating-factor expression. Biochem J 2001;356:525-530.
34. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21:193-215.
35. Stark K, Eckart A, Haidari S, Tirniceriu A, Lorenz M, von Bruhl ML, et al. Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and "instruct" them with pattern-recognition and motility programs. Nat Immunol 2013;14:41-51.
36. Morikawa H, Hachiya K, Mizuhara H, Fujiwara H, Nishiguchi S, Shiomi S, et al. Sublobular veins as the main site of lymphocyte adhesion/transmigration and adhesion molecule expression in the porto-sinusoidal-hepatic venous system during concanavalin A-induced hepatitis in mice. Hepatology 2000;31:83-94.
37. Wolf D, Hallmann R, Sass G, Sixt M, Kusters S, Fregien B, et al. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1-relevance for concanavalin A-induced hepatitis. J Immunol 2001;166:1300-1307.
38. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992;13:103-108.
39. Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1. Proc Natl Acad Sci USA 1993;90:9266-9270.
40. Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, Rao M, et al. The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol Appl Pharmacol 2001;177:112-120.
41. 2 mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury. Hepatology 2007;45:159-169.
42. Katagiri H, Ito Y, Ishii K, Hayashi I, Suematsu M, Yamashina S, et al. Role of thromboxane derived from COX-1 and -2 in hepatic microcirculatory dysfunction during endotoxemia in mice. Hepatology 2004;39:139-150.
43. Katagiri H, Ito Y, Ito S, Murata T, Yukihiko S, Narumiya S, et al. TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 2008;30:463-467.